Variants of the catechol-O-methyltransferase (COMT) gene, which represents a key regulator of dopaminergic neurotransmission and possibly a pharmacological target, has also been considered as a genetic predisposition factor to OCS in schizophrenia [44,45]. The gene discussed is COMT; the disease is schizophrenia.